There are circumstances where patients may require access to medicines or medical devices that have not been approved for supply by the TGA.
In these circumstances a medical practitioner may be granted authority to become an authorised prescriber of a specified unapproved therapeutic good (or class of unapproved therapeutic goods) to specific patients (or classes of recipients) with a particular medical condition.
The medical practitioner becomes an 'Authorised Prescriber' and can prescribe that product for that condition (also known as the 'indication') to individual patients in their immediate care without further TGA approval.
To be an Authorised Prescriber the medical practitioner must have:
- the training and expertise appropriate for the condition being treated and the proposed use of the product;
- the Authorised Prescriber must be able to best determine the needs of the patient; and
- to monitor the outcome of therapy.
An Authorised Prescriber is allowed to supply the product directly to specified patients under their immediate care and not to other practitioners who prescribe/administer the product. Use of the product under an authorisation must be at all times in line with the conditions specified in the authorisation.
Once a medical practitioner becomes an 'Authorised Prescriber' they do not need to notify the TGA when they are prescribing the unapproved product, however they must report to the TGA the number of patients treated on a six monthly basis.
- How to become an Authorised Prescriber
The TGA needs certain information as part of an application to become an Authorised Prescriber
- Obtaining endorsement from an Ethics Committee
Medical practitioners seeking to become Authorised Prescribers need to have their application endorsed by an ethics committee
- Obtaining the unapproved therapeutic goods as an Authorised Prescriber
If the medicine or medical device is available from a supplier in Australia, the Authorised Prescriber should contact the supplier (sponsor) to organise supply
- Access to unapproved therapeutic goods - Authorised Prescribers
Describes how medical practitioners in Australia can obtain approval as an 'Authorised Prescriber' for the purpose of supplying an unapproved therapeutic good and their obligations arising from such authorisations
- The TGA is collecting personal information in this form in order to:
- assess the application
- contact the medical practitioner and discuss the application where necessary
- The personal information of the medical practitioner may be disclosed to State and Territory authorities with responsibility for therapeutic goods or medical practitioner registration.
- For general privacy information, go to Privacy
These forms are available in pdf and Microsoft Word format. The pdf forms can be filled in and saved to your computer using Adobe Reader version 7 or later or any version of Adobe Acrobat Standard or Professional. If you have an earlier version of Adobe Reader you can fill in the form on-screen and print it out but you will not be able to save the completed form.
- Authorised prescriber - Agreement to treatment directions (pdf,77kb)
- Authorised prescriber - Agreement to treatment directions (Microsoft Word,194kb)
- Authorised prescriber - Consent to treatment and indemnity for use of products derived from biological tissues including human blood or plasma (pdf,62kb)
- Authorised prescriber - Consent to treatment and indemnity for use of products derived from biological tissues including human blood or plasma (Microsoft Word,192kb)
Send applications to:
- Fax: 02 6232 8112
- Post: The Medical Officer, Experimental Products Section, Office of Scientific Evaluation, Therapeutic Goods Administration, PO Box 100, Woden ACT 2606
If your enquiry is not about authorised prescribers, see: Contact the TGA
|Fax||+61 2 6232 8112|
|Postal address||The Medical Officer
Experimental Products Section
Office of Scientific Evaluation
Therapeutic Goods Administration
PO Box 100
Woden ACT 2606
|Therapeutic Goods Administration
136 Narrabundah Lane
Symonston ACT 2609
Web page last updated: Tuesday, 11 March 2014